$ABT
AI 分析生成於 May 18, 2026
AI Score
Buy$ABT
Abbott Laboratories
$ABTNYSEHealthcareLarge-Cap
Abbott discovers, develops, manufactures, and sells health care products worldwide in diagnostics, medical devices, nutrition, and pharmaceuticals.
Market Cap
$210B
Revenue (TTM)
$42.5B
+5.8%
Net Income (TTM)
$7.8B
+8.2%
EPS (TTM)
$4.52
P/E Ratio
26.8
Dividend Yield
1.8%
52-Week Range
$102-$128
Beta
0.72
Dimension Scores
Fundamental
76Technical
70Sentiment
72Risk / Reward
74Momentum
68Financial Health
Profitability
78moderate
Growth
68moderate
Liquidity
80strong
Solvency
78moderate
Efficiency
76moderate
Valuation, technical analysis, investment thesis, risk assessment and more for $ABT
Free · No credit card required
免責聲明: AI 生成的分析僅供教育參考,不構成投資建議。請始終諮詢合格的理財顧問。